8-KThe WireRed Alert
Executive Change
Filed Apr 24, 2026 · 2mo ago · Accession 0001193125-26-177406
Plain English
NewAmsterdam Pharma Company N.V. and its Chief Accounting Officer, Louise Kooij, agreed to her separation effective August 31, 2026, with a separation agreement entered into on April 24, 2026.
Filing details
- Company
- NewAmsterdam Pharma Co N.V.
- Ticker
- NAMS
- CIK
- 1936258
- Form type
- 8-K
- Filing date
- Apr 24, 2026
- Report date
- Apr 20, 2026
- Document
- nams-20260420.htm
- Size
- 198 KB